Aspirin bias in SPORTIF III trial.
Vadivelu
Murali Karthick
MK
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use; D001596:Benzylamines; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011355:Prodrugs / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D015983:Selection Bias; D020521:Stroke / Q000517:prevention & control*; D013917:Thrombin / Q000037:antagonists & inhibitors; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; D010975:Platelet Aggregation Inhibitors; D011355:Prodrugs; C426686:ximelagatran; D014859:Warfarin; D013917:Thrombin; D001241:Aspirin